Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial

Overview of attention for article published in The Lancet, April 2019

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (99th percentile)
High Attention Score compared to outputs of the same age and source (89th percentile)

So far, Altmetric has seen 4 posts from 2 blogs.

#NephJC SummaryTuesday, December 5th, 2023, at 9 pm EasternWednesday, December 6th, 2023, at 9 pm Indian Standard Time and 3:30…

#NephJC ChatTuesday May 23 at 9 pm Eastern (AEST = June 8th, 11am)Wednesday May 24, 2022, at 9 pm Indian Standard Time and 4:30…

Submit your picks! | NephMadness 2023 | #NephMadness | #IgAN Selection Committee Member: Dana Rizk @DanaRizk1 Dana Rizk is…

#NephJC Chat Tuesday June 11, at 9 pm EasternWednesday June 12 9 pm Indian Summer TimeWednesday June 12, 9 pm BST, 1 pm Pacific L…

This page shows the most recent blog posts that mention this research output. Click here to find out how to access more activity.